Tumor-associated macrophages in human breast, colorectal, lung, ovarian and prostate cancers

I Larionova, G Tuguzbaeva, A Ponomaryova… - Frontiers in …, 2020 - frontiersin.org
Tumor-associated macrophages (TAMs) are major innate immune cells that constitute up to
50% of the cell mass of human tumors. TAMs are highly heterogeneous cells that originate …

Tumor microenvironment promotes breast cancer chemoresistance

U Mehraj, AH Dar, NA Wani, MA Mir - Cancer chemotherapy and …, 2021 - Springer
Breast cancer is presently the most predominant tumor type and the second leading cause
of tumor-related deaths among women. Although advancements in diagnosis and …

[HTML][HTML] Tumor-associated macrophages in breast cancer: Innocent bystander or important player?

SQ Qiu, SJH Waaijer, MC Zwager, EGE de Vries… - Cancer treatment …, 2018 - Elsevier
Tumor-associated macrophages (TAMs) are important tumor-promoting cells in the breast
tumor microenvironment. Preclinically TAMs stimulate breast tumor progression, including …

Cancer-related inflammation and treatment effectiveness

CI Diakos, KA Charles, DC McMillan… - The Lancet …, 2014 - thelancet.com
Inflammation is a recognised hallmark of cancer that substantially contributes to the
development and progression of malignancies. In established cancers, there is increasing …

[HTML][HTML] The role of chronic inflammation in the development of breast cancer

DN Danforth - Cancers, 2021 - mdpi.com
Simple Summary Chronic inflammation is an important cause of multiple cancers. While
chronic inflammation is present in breast cancer and may influence its outcome, its role in …

The prognostic value of tumor-infiltrating lymphocytes in breast cancer: a systematic review and meta-analysis

Y Mao, Q Qu, X Chen, O Huang, J Wu, K Shen - PloS one, 2016 - journals.plos.org
Background The prognostic values of tumor-infiltrating lymphocytes (TILs) and TILs subsets
in breast cancer (BC) are uncertain. Methods A systematic literature search (MEDLINE, Web …

Tertiary lymphoid structures and B lymphocytes in cancer prognosis and response to immunotherapies

N Jacquelot, J Tellier, N Sl, B Gt - Oncoimmunology, 2021 - pmc.ncbi.nlm.nih.gov
Tertiary lymphoid structures (TLS) are ectopic cellular aggregates that resemble secondary
lymphoid organs in their composition and structural organization. In contrast to secondary …

Prognostic significance of PD-L1 and PD-L2 in breast cancer

MZ Baptista, LO Sarian, SFM Derchain, GA Pinto… - Human pathology, 2016 - Elsevier
Summary PD-L1 and PD-L2 constitute an important antitumor immune response. In breast
cancer, their prognostic value is still to be defined. In this study, we investigate the …

Breast cancer survival outcomes and tumor-associated macrophage markers: a systematic review and meta-analysis

E Allison, S Edirimanne, J Matthews, SJ Fuller - Oncology and Therapy, 2023 - Springer
Abstract Introduction Tumor-associated macrophages (TAMs) in breast cancer are
associated with a poor prognosis. Early studies of TAMs were largely limited to the pan …

The elevated preoperative platelet-to-lymphocyte ratio predicts poor prognosis in breast cancer patients

S Krenn-Pilko, U Langsenlehner, EM Thurner… - British journal of …, 2014 - nature.com
Background: The elevation of the platelet-to-lymphocyte ratio (PLR), an easily applicable
blood test based on platelet and lymphocyte counts has been associated with poor …